Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
VerAvanti
AddedFeb 16, 2024
UpdatedJun 18, 2026
VerAvanti

VerAvanti

Series A

VerAvanti: Innovating in medical device development through advanced science and patented technology.

HQ
Redmond, WA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

VerAvanti, founded with a mission to innovate in medical device development, leverages advanced science and patented technology to address critical gaps in medical treatment. The company focuses on creating solutions for ischemic strokes and Chronic Total Occlusion (CTO) therapy. Their flagship product, the Scanning Fiber Endoscope (SFE), is designed to provide interventional cardiologists with enhanced visualization capabilities, thereby improving diagnosis and treatment outcomes.

Notable figures affiliated with VerAvanti include experts in medical technology and seasoned investors who support its vision of transforming healthcare. The company has achieved significant milestones in developing its SFE technology, receiving patents and recognition within the medical community. VerAvanti's impact lies in its potential to revolutionize patient care by offering tools that enable more precise and effective interventions, ultimately aiming to reduce the incidence of untreated conditions and improve patient outcomes globally.

VerAvanti - Similar Companies

Avantis Medical Systems logo

Avantis Medical Systems

avantismedical.com

Avicena logo

Avicena

avicenaheart.com

Annoviant logo

Annoviant

Endovention logo

Endovention

Traverse Vascular logo

Traverse Vascular

Visie logo

Visie

visievision.com

FastWave Medical logo

FastWave Medical

InterVene logo

InterVene

intervene-med.com

Verix Health logo

Verix Health

Avive Solutions logo

Avive Solutions

avive.life

Scientia Vascular logo

Scientia Vascular

Iscience Surgical logo

Iscience Surgical

HeartVista logo

HeartVista

Venarum Medical logo

Venarum Medical

Scinovia logo

Scinovia

VerAvanti - Quick Facts

Who are VerAvanti's competitors?

Companies similar to VerAvanti include Avantis Medical Systems, Avicena, Annoviant and Endovention.

When was VerAvanti founded?

VerAvanti was founded in 2012.

Where is VerAvanti's headquarters located?

VerAvanti's headquarters is located in Redmond, WA, US.

When was VerAvanti's last funding round?

VerAvanti's most recent funding round was for $5M (USD) in July 2017.

How much has VerAvanti raised to-date?

As of Jul 17, 2017, VerAvanti has raised a total of $5M (USD).

How many employees does VerAvanti have?

VerAvanti has 16 employees as of Feb 5, 2024.

VerAvanti - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified